Skip to main content
Clinical Trials/CTRI/2018/07/014968
CTRI/2018/07/014968Not yet recruiting未知

Effect of oral zinc supplementation as an adjunct in the treatment of pneumonia.

Dr Kashmira Rajesh Mutha0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Hospitalized children from age 2 months till 12 years
  • 2.Diagnosed as pneumonia based on following criteria:
  • A.Fever, cough, difficulty in breathing B. B. B.Tachypnea (with/without chest retractions) defined as per WHO /IMCI age specific criteria
  • a)2 months to 12 months: Respiratory Rate > 50
  • b)12 months till 5 years: Respiratory Rate > 40
  • c) >5 years: Respiratory Rate >30

Exclusion Criteria

  • 1.Recurrent Pneumonia
  • 2.Congenital Heart Disease
  • 3.Severe Acute Malnutrition
  • 4.Tuberculosis
  • 5.Children on zinc supplements
  • 6.Documented allergy /Intolerance to zinc
  • 7.Chronic systemic illness
  • 8.Congenital GI malformations
  • 9.Hyper-reactive Airway Disease
  • 10.Radiological findings inconsistent with diagnosis of pneumonia

Investigators

Sponsor
Dr Kashmira Rajesh Mutha

Similar Trials